Skip to content
Join our community and subscribe to our free weekly newsletter
Subscribe
Toggle Navigation
Latest News
Articles
Live Talks
Trials Update
Prevention & Risk Factors
Science-Backed Dementia Prevention
Alzheimer’s Genetics & Risk Factors
Menopause
Long COVID
Dementias
Alzheimer’s Disease
Vascular Dementia
Frontotemporal Dementia (FTD)
Lewy Body Dementia
Traumatic Brain Injury & CTE
Brain Disorders
Mild Cognitive Impairment (MCI)
Parkinson’s Disease
Getting Diagnosed
Diagnosis
Journey to Diagnosis
Genetic Testing
Alzheimer’s Biomarkers
Diversity and Dementia
Caregivers
Caregiver Voices
Learning Guides
Search for:
Search for:
Simon Spichak, MSc
FDA Ups ARIA Monitoring for Aduhelm; Doubles MRI Requirement
16 People Are About to Help Test This Nasal Vaccine for Alzheimer’s
Dave Balbridge: An Advocacy Mission for Aging American Indians
Can Depression Cause Memory Loss?
This Blood Pressure Medication May Reduce Cognitive Decline Risk by 1/5
Genomic Forensics: Looking for Alzheimer’s “Signatures” on Cells
Is Alzheimer’s Genetic?
Biogen CEO Steps Down, Downsizing Sales of Aduhelm
Astrocytes: an Alzheimer’s Drug Target?
Tracking How the Brain Grows and Shrinks Over Time
5 Signs You Should Talk to a Doctor About Depression
Biogen Abandons Aduhelm Approval Process in Europe
What Is Tau — and Why Does It Matter in Alzheimer’s?
Ka`imi A. Sinclair on the Imperative of Alzheimer’s Awareness in American Indian Communities
CMS Says No Aduhelm Coverage for Patients Outside Clinical Trials
Previous
27
28
29
Next
Page load link
Go to Top